EUCOPE Blog

Showing all entries tagged with »Biotech«

December 19, 2022

Launch Conditionality: What’s at stake?

Based on current discussions by the European Commission, launch conditionalities would not account for the distinct nature of small and mid-sized companies, OMPs and ATMPs. EUCOPE’s Alexander Natz breaks down this aspect of the revision of the General Pharmaceutical Legislation… read more



May 15, 2020

ECRD 2020: OMPs Development in a post-COVID-19 World

The 10th European Conference on Rare Diseases (ECRD), the largest patient-led event on rare diseases and orphan products, presented an excellent opportunity for exchange among the patient community and experts from various backgrounds.  Bringing the perspective of OMP focused small… read more


March 12, 2019

Are Solutions for Rare Diseases in Jeopardy?

This blog was originally published in French, in Les Echos newspaper. How can we align the progress of medicine with the patients’ needs? How can we ensure that new life-saving medicines continue to be produced? How can Europe keep its… read more


February 1, 2019

EUCOPE 10-Year Anniversary Event – Thinking Ahead

You couldn’t have thought of a better stage. The Solvay Library, in Brussels, Belgium. Where some time ago, famous science pioneers such as Albert Einstein and Marie Curie gathered up to discuss breakthroughs and discoveries that will shape science and… read more